Cargando…

Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

BACKGROUND: We assessed the validity of a self-report measure of undetectable viral load (VL) among women with HIV in British Columbia (BC), Canada. Questionnaire data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study was linked with population-based clinical data from the BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Allison, de Pokomandy, Alexandra, Loutfy, Mona, Ding, Erin, Sereda, Paul, Webster, Kath, Nicholson, Valerie, Beaver, Kerrigan, Hogg, Robert S., Kaida, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366109/
https://www.ncbi.nlm.nih.gov/pubmed/28340606
http://dx.doi.org/10.1186/s13104-017-2453-8
_version_ 1782517529966542848
author Carter, Allison
de Pokomandy, Alexandra
Loutfy, Mona
Ding, Erin
Sereda, Paul
Webster, Kath
Nicholson, Valerie
Beaver, Kerrigan
Hogg, Robert S.
Kaida, Angela
author_facet Carter, Allison
de Pokomandy, Alexandra
Loutfy, Mona
Ding, Erin
Sereda, Paul
Webster, Kath
Nicholson, Valerie
Beaver, Kerrigan
Hogg, Robert S.
Kaida, Angela
author_sort Carter, Allison
collection PubMed
description BACKGROUND: We assessed the validity of a self-report measure of undetectable viral load (VL) among women with HIV in British Columbia (BC), Canada. Questionnaire data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study was linked with population-based clinical data from the BC Centre for Excellence in HIV/AIDS. Self-reported undetectable VL was assessed by the question: “What was your most recent VL, undetectable (i.e. <50 copies/mL) or detectable (i.e. ≥50 copies/mL)?” Laboratory measurements of VL <50 copies/mL (closest to/before study visit) were the criterion for validity analyses. We measured positive and negative predictive values (PPV, NPV) and likelihood ratios (LR+, LR−). RESULTS: Of 356 participants, 99% were linked to clinical data. Those unlinked (n = 1), missing self-report VL (n = 18), or missing self-report and laboratory VL (n = 1) were excluded. Among the remaining 336: median age was 44 (IQR 37–51); 96% identified as cis-gender; 84% identified as heterosexual; and 45% identified as Indigenous, 40% White, 8% African, Caribbean, or Black, and 8% other/multiple ethnicities. Overall, 85% self-reported having an undetectable VL while 82% had clinical data indicating viral suppression. The PPV was 93.7 (95% CI 90.2–96.2) indicating that 94% of women who self-reported being undetectable truly were. The NPV was 80.4 (95% CI 66.9–90.2). LR+ was 3.2 (2.1–4.6) and LR− was 0.05 (0.03–0.10). CONCLUSIONS: Our self-report measure assessing undetectable VL strongly predicted true viral suppression among Canadian women with HIV. This measure can be used in research settings without laboratory data in regions with high rates of VL testing and suppression.
format Online
Article
Text
id pubmed-5366109
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53661092017-03-28 Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study Carter, Allison de Pokomandy, Alexandra Loutfy, Mona Ding, Erin Sereda, Paul Webster, Kath Nicholson, Valerie Beaver, Kerrigan Hogg, Robert S. Kaida, Angela BMC Res Notes Short Report BACKGROUND: We assessed the validity of a self-report measure of undetectable viral load (VL) among women with HIV in British Columbia (BC), Canada. Questionnaire data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study was linked with population-based clinical data from the BC Centre for Excellence in HIV/AIDS. Self-reported undetectable VL was assessed by the question: “What was your most recent VL, undetectable (i.e. <50 copies/mL) or detectable (i.e. ≥50 copies/mL)?” Laboratory measurements of VL <50 copies/mL (closest to/before study visit) were the criterion for validity analyses. We measured positive and negative predictive values (PPV, NPV) and likelihood ratios (LR+, LR−). RESULTS: Of 356 participants, 99% were linked to clinical data. Those unlinked (n = 1), missing self-report VL (n = 18), or missing self-report and laboratory VL (n = 1) were excluded. Among the remaining 336: median age was 44 (IQR 37–51); 96% identified as cis-gender; 84% identified as heterosexual; and 45% identified as Indigenous, 40% White, 8% African, Caribbean, or Black, and 8% other/multiple ethnicities. Overall, 85% self-reported having an undetectable VL while 82% had clinical data indicating viral suppression. The PPV was 93.7 (95% CI 90.2–96.2) indicating that 94% of women who self-reported being undetectable truly were. The NPV was 80.4 (95% CI 66.9–90.2). LR+ was 3.2 (2.1–4.6) and LR− was 0.05 (0.03–0.10). CONCLUSIONS: Our self-report measure assessing undetectable VL strongly predicted true viral suppression among Canadian women with HIV. This measure can be used in research settings without laboratory data in regions with high rates of VL testing and suppression. BioMed Central 2017-03-24 /pmc/articles/PMC5366109/ /pubmed/28340606 http://dx.doi.org/10.1186/s13104-017-2453-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Carter, Allison
de Pokomandy, Alexandra
Loutfy, Mona
Ding, Erin
Sereda, Paul
Webster, Kath
Nicholson, Valerie
Beaver, Kerrigan
Hogg, Robert S.
Kaida, Angela
Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study
title Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study
title_full Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study
title_fullStr Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study
title_full_unstemmed Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study
title_short Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study
title_sort validating a self-report measure of hiv viral suppression: an analysis of linked questionnaire and clinical data from the canadian hiv women’s sexual and reproductive health cohort study
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366109/
https://www.ncbi.nlm.nih.gov/pubmed/28340606
http://dx.doi.org/10.1186/s13104-017-2453-8
work_keys_str_mv AT carterallison validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT depokomandyalexandra validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT loutfymona validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT dingerin validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT seredapaul validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT websterkath validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT nicholsonvalerie validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT beaverkerrigan validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT hoggroberts validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT kaidaangela validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy
AT validatingaselfreportmeasureofhivviralsuppressionananalysisoflinkedquestionnaireandclinicaldatafromthecanadianhivwomenssexualandreproductivehealthcohortstudy